María Jesús Martínez Usarralde
The heterogeneous presentation, variable histologic overlap with other lymphoproliferative disorders, and uncertain prognosis of PCSM-TCL creates diagnostic and management dilemmas for clinicians. For treatment, a distinction should be made between indolent and aggressive subtypes. Further investigation is needed to determine if PCSM-TCL is indeed a distinct lymphoma category and, additionally, if aggressive subtypes should remain part of the same diagnostic category.
Miguel Melendro EstefaníaÁngel de Juanas OlivaMaría Rosario Limón Mendizábal
Ángel Soler GuillénFernando Pascual
Laura Esmerys Feliz RosarioSilvia CarrascalJuana María Anguita Acero